When a warning letter from the U.S. Food and Drug Administration (FDA) arrives, the immediate reaction of...
Treatment Innovations
By Gwendolyn Wu | September 22, 2026 In a significant advancement for the treatment of autoimmune disorders,...
The rise of blockbuster weight-loss medications—specifically semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound)—has triggered a secondary, shadow market of...
The landscape of modern pharmacology shifted fundamentally in May 2026 with the U.S. FDA’s historic approval of...
As the global healthcare landscape undergoes a seismic shift driven by digital integration, miniaturization, and rigorous regulatory...
The landscape of American pharmaceutical pricing is currently defined by a high-stakes legislative experiment. President Donald Trump’s...
In a significant milestone for cardiac health technology, Israel-based medical device innovator CardiaCare has successfully closed an...
In a landmark development for diagnostic imaging, Koning Health has officially received regulatory clearance from Australia’s Therapeutic...
In a landmark development for ocular medicine, Beacon Therapeutics has announced that its investigational gene therapy, laru-zova,...
By Jonathan Gardner | September 21, 2026 In a pivotal "capital markets day" held in London this...
